Robuta

https://www.rcsb.org/structure/5EOL RCSB PDB - 5EOL: Crystal structure of human Pim-1 kinase in complex with a macrocyclic... Crystal structure of human Pim-1 kinase in complex with a macrocyclic quinoxaline-pyrrolodihydropiperidinone inhibitor https://www.southampton.ac.uk/courses/2027-28/modules/chem3040 Macrocyclic and Bio-inorganic Chemistry | CHEM3040 | University of Southampton This module explores some of the distinguishing features of metal ion complexes bearing macrocyclic ligands and some of the key structural and functional roles... inorganic chemistryuniversity ofmacrocyclicbiosouthampton https://www.rcsb.org/structure/8BI2 RCSB PDB - 8BI2: Syk kinase domain in complex with macrocyclic inhibitor 20a Syk kinase domain in complex with macrocyclic inhibitor 20a rcsb pdbsyk kinase https://www.ncbi.nlm.nih.gov/Structure/pdb/1NM6 1NM6: thrombin in complex with selective macrocyclic inhibitor at 1.8A Hirudinthrombin(11S)-11-BENZYL-6-CHLORO-1,2,10,11,12,13,14,15,16,17,18,19-DODECAHYDRO-5,9-METHANO-2,5,8,10,13,17-BENZOHEXAAZACYCLOHENI COSINE-3,24-DIONE at 1thrombincomplex https://www.ncbi.nlm.nih.gov/Structure/pdb/3N7Y 3N7Y: Crystal Structure of the Grb2 SH2 Domain in Complex with a 20-Membered Macrocyclic Ligand... 20-membered peptide-like macrocyclic ligandGrowth factor receptor-bound protein 2 https://www.southampton.ac.uk/courses/2026-27/modules/chem3040 Macrocyclic and Bio-inorganic Chemistry | CHEM3040 | University of Southampton This module explores some of the distinguishing features of metal ion complexes bearing macrocyclic ligands and some of the key structural and functional roles... inorganic chemistryuniversity ofmacrocyclicbiosouthampton https://www.ncbi.nlm.nih.gov/Structure/pdb/3N84 3N84: Crystal Structure of the Grb2 SH2 Domain in Complex with a 23-Membered Macrocyclic Ligand... 23-membered peptide-like macrocyclic ligandGrowth factor receptor-bound protein 2CHLORIDE IONGLYCEROL https://www.fiercebiotech.com/biotech/argenx-agrees-15b-pact-turn-unnatural-products-macrocyclic-peptides-new-targets Argenx's $1.5B pact to turn macrocyclic peptides to new targets Jul 1, 2025 - Argenx wants to get in on the macrocyclic peptide action, penning a deal worth $1.5 billion in biobucks with Unnatural Products. s 1argenx5bpact https://www.ncbi.nlm.nih.gov/Structure/pdb/1D4K 1D4K: HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR HIV-1 PROTEASEN-13-[(10S,13S)-9,12-DIOXO-10-(2-BUTYL)-2-OXA-8,11-DIAZABICYCLO [13.2.2] NONADECA-15,17,18-TRIENE] (2R)-BENZYL-(4S)-HYDROXY-5-AMINOPENTANOIC... hiv 1 proteasemacrocyclicpeptidomimeticinhibitor https://www.rcsb.org/structure/1B6J RCSB PDB - 1B6J: HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1 HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1 hiv 1 proteasercsb pdb https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1213920/full Frontiers | Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a... Introduction: The complement system is a key component of the innate immune system, and its aberrant activation underlies the pathophysiology of various dise... complement component 5 https://www.rcsb.org/structure/4JQL RCSB PDB - 4JQL: Synthesis of Benzoquinone-Ansamycin-Inspired Macrocyclic Lactams from Shikimic Acid Synthesis of Benzoquinone-Ansamycin-Inspired Macrocyclic Lactams from Shikimic Acid https://www.rcsb.org/structure/6QBG RCSB PDB - 6QBG: Crystal structure of human cathepsin D in complex with macrocyclic inhibitor 14 Crystal structure of human cathepsin D in complex with macrocyclic inhibitor 14 https://www.ncbi.nlm.nih.gov/Structure/pdb/1B6P 1B6P: HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 7 RETROPEPSINN-[3-(8-SEC-BUTYL-7,10-DIOXO-2-OXA-6,9-DIAZA-BICYCLO[11.2.2] HEPTADECA-1(16),13(17),14-TRIEN-11-YAMINO)-2-HYDROXY-1-(4-HYDROXY-BENZYL)... hiv 1 proteasemacrocyclicpeptidomimeticinhibitor7 https://www.rcsb.org/structure/7YF6 RCSB PDB - 7YF6: Crystal structure of HIV-1 protease in complex with macrocyclic peptide Crystal structure of HIV-1 protease in complex with macrocyclic peptide